SYDNEY, Australia and MINNEAPOLIS, Oct. 8 (Korea Bizwire) — Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF), is a mental health technology company that has pioneered the use of objective biometrics to assist in the screening, diagnosing, monitoring and management of depression and other mental health conditions, is pleased to announce it has entered into [...]
SYDNEY, Australia and MINNEAPOLIS, Jul. 19 (Korea Bizwire) — Medibio Limited (MEB or the Company) (ASX:MEB) (OTCQB:MDBIF), a digital health company that has developed an objective testing system to assist in the screening, diagnosis and treatment effectiveness of depression, chronic stress and other mental health disorders, is pleased to announce the appointment of Dr Adam [...]
SYDNEY, Australia and MINNEAPOLIS, Jul. 5 (Korea Bizwire) — Australian Stock Exchange listed medical technology company Medibio Limited (MEB or the Company) is pleased to announce the appointment of The Honourable Patrick J. Kennedy to the Board of Directors. Patrick J. Kennedy is a former member of the U.S. House of Representatives (D-R.I.) and the [...]
SYDNEY, Australia and MINNEAPOLIS, Jun. 26 (Korea Bizwire) — Australian Stock Exchange-listed medical technology company Medibio Limited (MEB or the Company) announces a new research study, conducted at Emory University, Atlanta GA and funded by Medibio, demonstrates that post-traumatic stress disorder (PTSD) can be accurately diagnosed using a non-invasive protocol involving heart rate data and [...]
SYDNEY, Australia, Jun. 5 (Korea Bizwire) — Medibio Limited (ASX:MEB) (MEB or the Company), an ASX listed medical technology company that has developed an effective objective test to assist in the diagnosis of depression, chronic stress and other mental health disorders, today announces the appointment of Michael Phelps, the most decorated swimmer in history and [...]